Quick Answer
BIO-TECHNE Corp reported Stockholders Equity of $2.07 billion for the year ending 2024.
- BIO-TECHNE Corp showed an increase of +5.2% in Stockholders Equity from 2023 to 2024.
- This data is from BIO-TECHNE Corp's annual report (Form 10-K), filed with the SEC on August 22, 2024.
- XBRL data for this metric is available from 2008 to 2024 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2010: $523.57 million | Q4 2010: $541.94 million | Q1 2011: $566.28 million | Q3 2011: $589.35 million | Q4 2011: $597.51 million | Q1 2012: $644.50 million | Q3 2012: $680.61 million | Q4 2012: $694.57 million | Q1 2013: $719.51 million | Q3 2013: $726.76 million | Q4 2013: $748.53 million | Q1 2014: $777.04 million | Q3 2014: $793.41 million | Q4 2014: $820.68 million | Q1 2015: $820.07 million | Q3 2015: $837.95 million | Q4 2015: $856.34 million | Q1 2016: $852.96 million | Q3 2016: $895.37 million | Q4 2016: $890.57 million | Q1 2017: $907.93 million | Q3 2017: $960.08 million | Q4 2017: $997.82 million | Q1 2018: $1.06 billion | Q3 2018: $1.11 billion | Q4 2018: $1.10 billion | Q1 2019: $1.15 billion | Q2 2019: $1.17 billion | Q3 2019: $1.17 billion | Q4 2019: $1.32 billion | Q1 2020: $1.29 billion | Q3 2020: $1.44 billion | Q4 2020: $1.52 billion | Q1 2021: $1.54 billion | Q3 2021: $1.64 billion | Q4 2021: $1.70 billion | Q1 2022: $1.71 billion | Q3 2022: $1.75 billion | Q4 2022: $1.83 billion | Q1 2023: $1.89 billion | Q2 2023: $1.97 billion | Q3 2023: $2.00 billion | Q4 2023: $1.96 billion | Q1 2024: $2.01 billion | Q2 2024: $2.07 billion | Q3 2024: $2.14 billion | Q4 2024: $2.08 billion | Q1 2025: $2.02 billion | Q2 2025: $1.92 billion | Q4 2025: $2.01 billion.
- Over the full 17 years of available data (2008 to 2024), BIO-TECHNE Corp's Stockholders Equity has grown by 324.7%.
- Historical annual values: Fiscal year 2024: $2.07 billion | Fiscal year 2023: $1.97 billion | Fiscal year 2022: $1.70 billion | Fiscal year 2021: $1.56 billion | Fiscal year 2020: $1.38 billion | Fiscal year 2019: $1.17 billion | Fiscal year 2018: $1.08 billion | Fiscal year 2017: $949.63 million | Fiscal year 2016: $879.28 million | Fiscal year 2015: $846.94 million | Fiscal year 2014: $795.27 million | Fiscal year 2013: $737.54 million | Fiscal year 2012: $674.44 million | Fiscal year 2011: $586.12 million | Fiscal year 2010: $501.79 million | Fiscal year 2009: $456.48 million | Fiscal year 2008: $487.13 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: